HCA Healthcare, Inc. (NYSE:HCA) Shares Acquired by Asahi Life Asset Management CO. LTD.

Asahi Life Asset Management CO. LTD. raised its holdings in HCA Healthcare, Inc. (NYSE:HCAGet Rating) by 26.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,010 shares of the company’s stock after acquiring an additional 415 shares during the quarter. Asahi Life Asset Management CO. LTD.’s holdings in HCA Healthcare were worth $369,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently bought and sold shares of the company. SeaCrest Wealth Management LLC acquired a new position in shares of HCA Healthcare in the 2nd quarter valued at about $33,000. Private Trust Co. NA bought a new stake in HCA Healthcare during the second quarter worth approximately $33,000. Glassman Wealth Services boosted its position in shares of HCA Healthcare by 28.7% in the second quarter. Glassman Wealth Services now owns 233 shares of the company’s stock valued at $39,000 after acquiring an additional 52 shares during the period. Covestor Ltd boosted its position in shares of HCA Healthcare by 122.7% in the first quarter. Covestor Ltd now owns 167 shares of the company’s stock valued at $42,000 after acquiring an additional 92 shares during the period. Finally, Bank Julius Baer & Co. Ltd Zurich boosted its position in shares of HCA Healthcare by 174.4% in the third quarter. Bank Julius Baer & Co. Ltd Zurich now owns 236 shares of the company’s stock valued at $43,000 after acquiring an additional 150 shares during the period. 64.60% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other HCA Healthcare news, SVP Phillip G. Billington sold 8,332 shares of the firm’s stock in a transaction dated Friday, October 28th. The stock was sold at an average price of $222.58, for a total transaction of $1,854,536.56. Following the transaction, the senior vice president now owns 40,652 shares in the company, valued at $9,048,322.16. The sale was disclosed in a document filed with the SEC, which is available through this link. In other news, insider A Bruce Moore, Jr. sold 10,000 shares of HCA Healthcare stock in a transaction dated Friday, November 11th. The stock was sold at an average price of $224.07, for a total transaction of $2,240,700.00. Following the transaction, the insider now owns 30,807 shares in the company, valued at approximately $6,902,924.49. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Phillip G. Billington sold 8,332 shares of HCA Healthcare stock in a transaction dated Friday, October 28th. The shares were sold at an average price of $222.58, for a total value of $1,854,536.56. Following the transaction, the senior vice president now owns 40,652 shares in the company, valued at approximately $9,048,322.16. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 28,170 shares of company stock worth $6,294,030. Insiders own 1.50% of the company’s stock.

HCA Healthcare Stock Down 0.3 %

HCA stock traded down $0.82 during midday trading on Wednesday, reaching $251.86. The stock had a trading volume of 170,367 shares, compared to its average volume of 1,344,648. The business has a fifty day simple moving average of $243.28 and a two-hundred day simple moving average of $218.23. The firm has a market cap of $71.21 billion, a price-to-earnings ratio of 14.28, a PEG ratio of 2.00 and a beta of 1.65. HCA Healthcare, Inc. has a twelve month low of $164.47 and a twelve month high of $279.02.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the company. Royal Bank of Canada reduced their price objective on HCA Healthcare from $249.00 to $239.00 and set an “outperform” rating for the company in a research report on Monday, October 24th. SVB Leerink raised their target price on HCA Healthcare from $238.00 to $286.00 and gave the stock an “outperform” rating in a research report on Friday, December 16th. Citigroup raised their target price on HCA Healthcare from $240.00 to $251.00 and gave the stock a “buy” rating in a research report on Wednesday, October 26th. Credit Suisse Group reduced their target price on HCA Healthcare to $240.00 in a research report on Thursday, October 27th. Finally, Stephens dropped their price objective on HCA Healthcare from $230.00 to $220.00 and set an “overweight” rating for the company in a research note on Monday, October 24th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and a consensus target price of $250.25.

HCA Healthcare Company Profile

(Get Rating)

HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Recommended Stories

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAGet Rating).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.